Executives On The Move: Departures At Ipsen And Novo Nordisk And A Board Change At PDL BioPharma
The CEO of Ipsen Group departs to take top job at new gene therapy company FerGene and Novo Nordisk’s VP, regulatory affairs moves to EVP, quality and regulatory at Scandinavian orthobiologics firm BoneSupport. At commercial-stage pharma business PDL BioPharma, a chairperson is elected.
You may also be interested in...
Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A Roche director joins predictive drug discovery firm Compugen and a Bristol-Myers Squibb exec is welcomed at immuno-oncology company Turnstone Biologics – both in Business Development. And China- and US-based biopharma Antegene brings on Celgene manager as CBO.